Publications

Paumi CM, Chuk M, Chevelev I, Stagljar I, and Michaelis S. Yeast ABC Transporters and Their Interactors: New Technology that will Advance MRP Biology, MMBR Invited Review - Manuscript in Preparation

Paumi CM, Engels K, Iyer K, Georgiev O, Michaelis S, and Stagljar I. Identification of Proteins that Interact with the Yeast MRP Transporter Ycf1p, Using the Membrane Yeast Two-Hybrid (MbYTH) Split-Ubiquitin System, Mol Cell. 2007 Apr 13;26(1):15-25.

O’Flaherty JT, Rogers LC, Paumi CM, Hantgan RR, Thomas LR, Clay CE, High KP, Chen YQ, Willingham MC, Kute TE, Rao A, Cramer SD, Morrow CS. 5-Oxo-ETE analogs and the proliferation of cancer cells. Biochim Biophys Acta. 2005 Oct 1;1736(3):228-36.

Paumi CM, Smitherman PK, Townsend AJ, Morrow CS. Glutathione S-Transferase (GSTs) Inhibit Transcriptional Activation by the Peroxisomal Proliferator-Activated Receptor g (PPARg) Ligand, 15-deoxy-delta (12,14)-prostaglandin J2 (15-d-PGJ­2). Biochemistry. 2004 Mar 2;43(8):2345-52.

Paumi CM, Wright M, Townsend AJ, Morrow CS. Multidrug resistance protein 1 (MRP1) and MRP3 attenuate cytotoxic and transactivating effects of cyclopentenone prostaglandin, 15-deoxy-delta (12,14)-prostaglandin J2 in MCF7 breast cancer cells. Biochemistry. 42:5429-5437 (2003)

Paumi CM, Ledford BG, Smitherman PK, Townsend AJ, Morrow CS. Role of multidrug resistance protein 1 (MRP1) and glutathione S-transferase A1-1 in alkylating agent resistance. Kinetics of glutathione conjugate formation and efflux govern differential cellular sensitivity to chlorambucil versus melphalan toxicity. J Biol Chem. 276:7952-6 (2001)

Hantgan RR, Paumi C, Rocco M, Weisel JW. Effects of ligand-mimetic peptides Arg-Gly-Asp-X (X = Phe, Trp, Ser) on alphaIIbbeta3 integrin conformation and oligomerization. Biochemistry. 38:14461-74 (1999)